TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Shanghai MicroPort MedBot (Group) Co., Ltd. Class H ( (HK:2252) ) has issued an announcement.
Shanghai MicroPort MedBot (Group) Co., Ltd. announced the establishment of a Strategy and Development Committee under its board of directors. This committee is tasked with researching and proposing long-term development strategies and major decisions to strengthen the company’s strategic development, optimize investment decision procedures, and improve decision-making effectiveness. The committee will also review and evaluate the company’s financial, marketing, operational, and business performance, as well as study market trends and their potential effects on the company’s growth.
The most recent analyst rating on (HK:2252) stock is a Sell with a HK$20.00 price target. To see the full list of analyst forecasts on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H stock, see the HK:2252 Stock Forecast page.
More about Shanghai MicroPort MedBot (Group) Co., Ltd. Class H
Shanghai MicroPort MedBot (Group) Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, focusing on strategic development in the medical technology industry. The company aims to enhance its core competitiveness and improve investment decision-making processes.
Average Trading Volume: 5,962,532
Technical Sentiment Signal: Buy
Current Market Cap: HK$22.42B
See more data about 2252 stock on TipRanks’ Stock Analysis page.